Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folexco/East Earth Herb

This article was originally published in The Tan Sheet

Executive Summary

Botanical extracts manufacturer changes name to A.M. Todd Botanicals and extends line of branded extracts with Astragamax, "a highly concentrated multi-standard pure astragalus extract." Available in powder form, Astragamax "includes guaranteed levels of the plant's active constituents: saponins, polysaccharides and flavonoids," the company says. In September, the firm launched its new line of branded extracts with Echinamax echinacea extract (1"The Tan Sheet" Sept. 13, In Brief). The Montgomeryville, Penn.-based manufacturer also is introducing a full line of standardized herbal extracts in granulated form, including echinacea, green tea, St. John's wort and Siberian ginseng

You may also be interested in...



Folexco/East Earth Herb

Botanical extracts manufacturer is targeting dietary supplement, functional food and beverage and health food industries with the launch of Echinamax. Shipping now, the product is described as the first available branded echinacea extract with higher amounts of the plant's active constituents - polysaccharides, phenolics and alkylamides. Advertising, handled by Doylestown, Penn.-based Macrovision Marketing Communications, is planned for upcoming issues of trade publications. Montgomeryville, Penn.-based Folexco acquired a controlling percentage in Eugene, Ore.-based East Earth Herb in April (1"The Tan Sheet" May 3, In Brief)

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS090534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel